Tandem CCO Brian Hansen resigns, to stay on leave through June 2024

TANDEM DIABETES CARE INC

Brian Hansen resigns as EVP & CCO effective Dec 31, 2023; remains employed through June 28, 2024 on paid administrative leave.
Will receive base salary through separation date, 2023 corporate bonus, and continued vesting of stock options and RSUs through June 28, 2024.
Company will pay COBRA premiums for up to six months after Dec 31, 2023 (through June 30, 2024).
Agreement includes 12-month non-solicitation of employees and a standard release of claims; full terms in Exhibit 10.1.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brian B. Hansen

Executive Vice President and Chief Commercial Officer

TNDM · TANDEM DIABETES CARE INC

Effective: 2023-12-31
Filed: August 18, 2023, 7:59 PM ET

On August 17, 2023, Brian B. Hansen, Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the Company), notified the Company of his decision to resign from his role as Executive Vice President and Chief Commercial Officer, effective December 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian B. Hansen resigned as Executive Vice President and Chief Commercial Officer at TANDEM DIABETES CARE INC.

Action: resigned
Role: Executive Vice President and Chief Commercial Officer

Exact text from the filing

On August 17, 2023, Brian B. Hansen, Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the Company), notified the Company of his decision to resign from his role as Executive Vice President and Chief Commercial Officer, effective December 31, 2023.

View on SEC.gov

TANDEM DIABETES CARE INC filing history →

Source: SEC EDGAR

accession 0001438133-23-000179

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.